These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
637 related articles for article (PubMed ID: 25869642)
61. 18β-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination. Zhou J; Cai W; Jin M; Xu J; Wang Y; Xiao Y; Hao L; Wang B; Zhang Y; Han J; Huang R Sci Rep; 2015 Sep; 5():13713. PubMed ID: 26329786 [TBL] [Abstract][Full Text] [Related]
62. Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Responses and Effects on Experimental Autoimmune Encephalomyelitis. Dieu RS; Wais V; Sørensen MZ; Marczynska J; Dubik M; Kavan S; Thomassen M; Burton M; Kruse T; Khorooshi R; Owens T Front Neurosci; 2021; 15():685645. PubMed ID: 34211367 [TBL] [Abstract][Full Text] [Related]
63. 2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model. Choi BY; Sim CK; Cho YS; Sohn M; Kim YJ; Lee MS; Suh SW Neurosci Lett; 2016 Aug; 628():78-84. PubMed ID: 27297771 [TBL] [Abstract][Full Text] [Related]
64. Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair. Mohajeri M; Sadeghizadeh M; Najafi F; Javan M Neuropharmacology; 2015 Dec; 99():156-67. PubMed ID: 26211978 [TBL] [Abstract][Full Text] [Related]
65. The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis. O'Brien K; Fitzgerald D; Rostami A; Gran B J Neuroimmunol; 2010 Apr; 221(1-2):107-11. PubMed ID: 20138374 [TBL] [Abstract][Full Text] [Related]
66. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model. Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483 [TBL] [Abstract][Full Text] [Related]
67. Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia. Wang Y; Bi Y; Xia Z; Shi W; Li B; Li B; Chen L; Guo L Biochem Biophys Res Commun; 2018 Feb; 497(1):80-86. PubMed ID: 29407174 [TBL] [Abstract][Full Text] [Related]
68. Comparison of the amelioration effects of two enzyme inducers on the inflammatory process of experimental allergic encephalitis (EAE) using immunohistochemical technique. El-Gouhary I; Mohamed A; Suleiman S; Benghuzzi H Biomed Sci Instrum; 2005; 41():376-81. PubMed ID: 15850135 [TBL] [Abstract][Full Text] [Related]
69. Dihydrotestosterone as a Protective Agent in Chronic Experimental Autoimmune Encephalomyelitis. Giatti S; Rigolio R; Romano S; Mitro N; Viviani B; Cavaletti G; Caruso D; Garcia-Segura LM; Melcangi RC Neuroendocrinology; 2015; 101(4):296-308. PubMed ID: 25765436 [TBL] [Abstract][Full Text] [Related]
70. Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord. Oji S; Nicolussi EM; Kaufmann N; Zeka B; Schanda K; Fujihara K; Illes Z; Dahle C; Reindl M; Lassmann H; Bradl M PLoS One; 2016; 11(3):e0151244. PubMed ID: 26990978 [TBL] [Abstract][Full Text] [Related]
71. CCR5 knockout suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice. Gu SM; Park MH; Yun HM; Han SB; Oh KW; Son DJ; Yun JS; Hong JT Oncotarget; 2016 Mar; 7(13):15382-93. PubMed ID: 26985768 [TBL] [Abstract][Full Text] [Related]
72. Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy. González LF; Acuña E; Arellano G; Morales P; Sotomayor P; Oyarzun-Ampuero F; Naves R J Control Release; 2021 Mar; 331():443-459. PubMed ID: 33220325 [TBL] [Abstract][Full Text] [Related]
73. Multiple pathological mechanisms contribute to hippocampal damage in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Kyran EL; Robinson C; Kocovski P; Li Z; Dang PT; Hale MW; Orian JM Neuroreport; 2018 Jan; 29(1):19-24. PubMed ID: 29194293 [TBL] [Abstract][Full Text] [Related]
74. Matrine Inhibits CNS Autoimmunity Through an IFN-β-Dependent Mechanism. Chu YJ; Ma WD; Thome R; Ping JD; Liu FZ; Wang MR; Zhang ML; Zhang G; Zhu L Front Immunol; 2020; 11():569530. PubMed ID: 33101289 [TBL] [Abstract][Full Text] [Related]
75. Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis. van Loo G; Sze M; Bougarne N; Praet J; Mc Guire C; Ullrich A; Haegeman G; Prinz M; Beyaert R; De Bosscher K Mol Endocrinol; 2010 Feb; 24(2):310-22. PubMed ID: 19965930 [TBL] [Abstract][Full Text] [Related]
76. Poly (I:C) downregulates platelet production and function through type I interferon. Rivadeneyra L; Pozner RG; Meiss R; Fondevila C; Gómez RM; Schattner M Thromb Haemost; 2015 Nov; 114(5):982-93. PubMed ID: 26134179 [TBL] [Abstract][Full Text] [Related]
77. Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitis. Gruber RC; Ray AK; Johndrow CT; Guzik H; Burek D; de Frutos PG; Shafit-Zagardo B J Neurosci; 2014 Dec; 34(49):16320-35. PubMed ID: 25471571 [TBL] [Abstract][Full Text] [Related]
78. Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE). Askari VR; Baradaran Rahimi V; Tabatabaee SA; Shafiee-Nick R Int Immunopharmacol; 2019 Dec; 77():105923. PubMed ID: 31711937 [TBL] [Abstract][Full Text] [Related]
79. A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. Gimenez MA; Sim J; Archambault AS; Klein RS; Russell JH Am J Pathol; 2006 Apr; 168(4):1200-9. PubMed ID: 16565495 [TBL] [Abstract][Full Text] [Related]
80. HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection. Benedek G; Meza-Romero R; Jordan K; Keenlyside L; Offner H; Vandenbark AA J Neuroinflammation; 2015 Jun; 12():123. PubMed ID: 26104759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]